12 Health Care Stocks Moving In Thursday's Pre-Market Session

Loading...
Loading...

 

Gainers

  • Dermata Therapeutics DRMA stock moved upwards by 27.1% to $1.36 during Thursday's pre-market session. The company's market cap stands at $11.3 million.
  • Reshape Lifesciences RSLS shares increased by 12.59% to $1.34. The market value of their outstanding shares is at $4.6 million.
  • Check out this: Insiders Buy Over $43M Of 4 Stocks
  • Marker Therapeutics MRKR shares rose 10.0% to $0.66. The company's market cap stands at $54.8 million.
  • Accuray ARAY shares rose 9.97% to $4.3. The company's market cap stands at $398.7 million.
  • Quoin Pharmaceuticals QNRX shares rose 9.79% to $1.57. The market value of their outstanding shares is at $13.1 million.
  • Mainz Biomed MYNZ shares moved upwards by 9.05% to $14.21. The company's market cap stands at $195.1 million.

 

Losers

  • ENDRA Life Sciences NDRA stock declined by 28.6% to $0.4 during Thursday's pre-market session. The company's market cap stands at $16.8 million.
  • Seagen SGEN stock decreased by 15.84% to $119.02. The company's market cap stands at $21.7 billion. As per the press release, Q4 earnings came out yesterday.
  • Aeglea BioTherapeutics AGLE shares fell 11.14% to $3.43. The market value of their outstanding shares is at $169.1 million.
  • Vera Therapeutics VERA shares declined by 9.19% to $17.3. The company's market cap stands at $368.1 million.
  • Alterity Therapeutics ATHE shares decreased by 7.21% to $0.9. The market value of their outstanding shares is at $36.1 million.
  • Biophytis BPTS shares fell 6.58% to $4.26. The company's market cap stands at $54.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...